Revenue Breakdown
Composition ()
No data
Revenue Streams
IRadimed Corp (IRMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is MRI Compatible IV Infusion Pump Systems, accounting for 39.3% of total sales, equivalent to $8.33M. Other significant revenue streams include MRI Compatible Patient Vital Signs Monitoring Systems and Disposables, services and other. Understanding this composition is critical for investors evaluating how IRMD navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, IRadimed Corp maintains a gross margin of 77.80%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 32.23%, while the net margin is 26.30%. These profitability ratios, combined with a Return on Equity (ROE) of 23.31%, provide a clear picture of how effectively IRMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, IRMD competes directly with industry leaders such as CNMD and ENOV. With a market capitalization of $1.25B, it holds a leading position in the sector. When comparing efficiency, IRMD's gross margin of 77.80% stands against CNMD's 56.59% and ENOV's 52.23%. Such benchmarking helps identify whether IRadimed Corp is trading at a premium or discount relative to its financial performance.
